{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T15:42:57Z","timestamp":1786203777541,"version":"build-2736575974"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"RM Partners, PAN London Cancer Alliance"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Exercise is considered safe for patients with myeloma, but evidence specific to multiple myeloma bone disease (MMBD) is unclear. Scoping review aims: 1) Review the literature on exercise interventions for myeloma patients that included those with MMBD 2) Map reporting of safety, assessment and intervention characteristics 3) Identify bone-related outcomes measuring changes in MMBD 4) Highlight research priorities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>Following the Joanna Briggs Institute framework, a comprehensive search of PubMed, OVID-MEDLINE, and CINAHL between 1946 to October 2025 was conducted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twelve studies met inclusion criteria, though none focused exclusively on MMBD patients. Reporting of MMBD characteristics varied; across 346 participants, prevalence ranged from 69\u201386%. There were 7 exercise-related adverse events, but it was not reported if they occurred in MMBD patients. Most studies used medical clearance, imaging, or standardized tools to assess participants\u2019 suitability for exercise. However, procedures varied between studies and haematological considerations were generally not utilised. Patients were commonly excluded if they had spinal instability, spinal cord compression or were at risk of a fracture. Interventions occurred across all disease stages and commonly involved tailored, supervised\/ unsupervised aerobic and resistance exercise, led by physiotherapists. However, practitioner experience, exercise modifications for MMBD and bone-related outcomes were infrequently reported, limiting clinical application.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Exercise appears safe for MMBD patients under certain exclusion criteria, but inconsistent reporting of adverse events in MMBD patients, MMBD characteristics, assessments, and exercise adaptations limits clinical translation, highlighting the need for targeted trials with only MMBD patients and bone-specific outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00520-026-10958-7","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T20:33:29Z","timestamp":1783974809000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exercise for myeloma patients with bone disease: a scoping review"],"prefix":"10.1007","volume":"34","author":[{"given":"Joanne","family":"Land","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orla","family":"McCourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalampia","family":"Kyriakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwee","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"10958_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2025.100680","volume":"52","author":"MT Gundesen","year":"2025","unstructured":"Gundesen MT, Schjesvold F, Lund T (2025) Treatment of myeloma bone disease: when, how often, and for how long? J Bone Oncol 52:100680","journal-title":"J Bone Oncol"},{"key":"10958_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11113088","author":"N Kanellias","year":"2022","unstructured":"Kanellias N et al (2022) Newly diagnosed multiple myeloma patients with skeletal-related events and abnormal MRI pattern have poor survival outcomes: a prospective study on 370 patients. J Clin Med. https:\/\/doi.org\/10.3390\/jcm11113088","journal-title":"J Clin Med"},{"issue":"8","key":"10958_CR3","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1093\/annonc\/mdi235","volume":"16","author":"E Terpos","year":"2005","unstructured":"Terpos E, Dimopoulos MA (2005) Myeloma bone disease: pathophysiology and management. Ann Oncol 16(8):1223\u20131231","journal-title":"Ann Oncol"},{"issue":"5","key":"10958_CR4","doi-asserted-by":"publisher","first-page":"571","DOI":"10.14444\/5070","volume":"12","author":"MS Patel","year":"2018","unstructured":"Patel MS et al (2018) Evaluating treatment strategies for spinal lesions in multiple myeloma: a review of the literature. Int J Spine Surg 12(5):571\u2013581","journal-title":"Int J Spine Surg"},{"issue":"1","key":"10958_CR5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/bjh.14815","volume":"179","author":"G McIlroy","year":"2017","unstructured":"McIlroy G et al (2017) Increased fracture risk in plasma cell dyscrasias is associated with poorer overall survival. Br J Haematol 179(1):61\u201365","journal-title":"Br J Haematol"},{"issue":"2","key":"10958_CR6","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00520-013-1991-4","volume":"22","author":"K Jordan","year":"2014","unstructured":"Jordan K et al (2014) Effect of general symptom level, specific adverse events, treatment patterns, and patient characteristics on health-related quality of life in patients with multiple myeloma: results of a European, multicenter cohort study. Support Care Cancer 22(2):417\u2013426","journal-title":"Support Care Cancer"},{"issue":"9","key":"10958_CR7","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1007\/s00277-020-04356-0","volume":"100","author":"LK Nielsen","year":"2021","unstructured":"Nielsen LK et al (2021) Health-related quality of life in patients with multiple myeloma participating in a multidisciplinary rehabilitation program. Ann Hematol 100(9):2311\u20132323","journal-title":"Ann Hematol"},{"issue":"5","key":"10958_CR8","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1177\/1078155219881489","volume":"26","author":"S Ailawadhi","year":"2020","unstructured":"Ailawadhi S et al (2020) Healthcare resource utilization and costs in patients with multiple myeloma with and without skeletal-related events. J Oncol Pharm Pract 26(5):1070\u20131079","journal-title":"J Oncol Pharm Pract"},{"issue":"2","key":"10958_CR9","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/s41416-020-0866-y","volume":"123","author":"DA Koutoukidis","year":"2020","unstructured":"Koutoukidis DA et al (2020) Fatigue, quality of life and physical fitness following an exercise intervention in multiple myeloma survivors (MASCOT): an exploratory randomised Phase 2 trial utilising a modified Zelen design. Br J Cancer 123(2):187\u2013195","journal-title":"Br J Cancer"},{"key":"10958_CR10","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.apnr.2017.03.003","volume":"35","author":"SR Mazanec","year":"2017","unstructured":"Mazanec SR et al (2017) A family-centered intervention for the transition to living with multiple myeloma as a chronic illness: a pilot study. Appl Nurs Res 35:86\u201389","journal-title":"Appl Nurs Res"},{"issue":"5","key":"10958_CR11","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1097\/00002820-200310000-00012","volume":"26","author":"EA Coleman","year":"2003","unstructured":"Coleman EA et al (2003) Feasibility of exercise during treatment for multiple myeloma. Cancer Nurs 26(5):410\u2013419","journal-title":"Cancer Nurs"},{"issue":"11","key":"10958_CR12","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1007\/s00520-004-0668-4","volume":"12","author":"LW Jones","year":"2004","unstructured":"Jones LW et al (2004) Association between exercise and quality of life in multiple myeloma cancer survivors. Support Care Cancer 12(11):780\u2013788","journal-title":"Support Care Cancer"},{"issue":"2","key":"10958_CR13","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.clml.2022.10.003","volume":"23","author":"JL Nicol","year":"2023","unstructured":"Nicol JL et al (2023) Safety, feasibility, and efficacy of exercise interventions for people with multiple myeloma: a systematic review. Clin Lymphoma Myeloma Leuk 23(2):86\u201396","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"3","key":"10958_CR14","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1007\/s11764-021-01062-2","volume":"16","author":"JL Nicol","year":"2022","unstructured":"Nicol JL et al (2022) Promoting exercise for patients with multiple myeloma: attitudes and practices of clinical haematologists. J Cancer Surviv 16(3):688\u2013695","journal-title":"J Cancer Surviv"},{"issue":"4","key":"10958_CR15","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3803\/EnM.2018.33.4.435","volume":"33","author":"AR Hong","year":"2018","unstructured":"Hong AR, Kim SW (2018) Effects of resistance exercise on bone health. Endocrinol Metab (Seoul) 33(4):435\u2013444","journal-title":"Endocrinol Metab (Seoul)"},{"key":"10958_CR16","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.critrevonc.2015.11.005","volume":"98","author":"JH Gan","year":"2016","unstructured":"Gan JH, Sim CY, Santorelli LA (2016) The effectiveness of exercise programmes in patients with multiple myeloma: a literature review. Crit Rev Oncol Hematol 98:275\u2013289","journal-title":"Crit Rev Oncol Hematol"},{"issue":"18","key":"10958_CR17","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1200\/JCO.2012.47.7901","volume":"31","author":"E Terpos","year":"2013","unstructured":"Terpos E et al (2013) International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone disease. J Clin Oncol 31(18):2347\u20132357","journal-title":"J Clin Oncol"},{"key":"10958_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71","journal-title":"BMJ"},{"issue":"1","key":"10958_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/XEB.0000000000000277","volume":"19","author":"MDJ Peters","year":"2021","unstructured":"Peters MDJ et al (2021) Updated methodological guidance for the conduct of scoping reviews. JBI Evid Implement 19(1):3\u201310","journal-title":"JBI Evid Implement"},{"issue":"3","key":"10958_CR20","first-page":"235","volume":"33","author":"A Kollikowski","year":"2025","unstructured":"Kollikowski A et al (2025) Feasibility and safety of impact-loading exercise in patients with multiple myeloma-a pilot study. Support Care Cancer 33(3):235","journal-title":"Support Care Cancer"},{"key":"10958_CR21","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s40814-019-0518-2","volume":"5","author":"RF Larsen","year":"2019","unstructured":"Larsen RF et al (2019) Supervised and home-based physical exercise in patients newly diagnosed with multiple myeloma-a randomized controlled feasibility study. Pilot Feasibility Stud 5:130","journal-title":"Pilot Feasibility Stud"},{"issue":"3","key":"10958_CR22","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/ejh.14215","volume":"113","author":"RF Larsen","year":"2024","unstructured":"Larsen RF et al (2024) Exercise in newly diagnosed patients with multiple myeloma: a randomized controlled trial of effects on physical function, physical activity, lean body mass, bone mineral density, pain, and quality of life. Eur J Haematol 113(3):298\u2013309","journal-title":"Eur J Haematol"},{"issue":"7","key":"10958_CR23","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1080\/0284186X.2023.2178326","volume":"62","author":"O McCourt","year":"2023","unstructured":"McCourt O et al (2023) Exercise prehabilitation for people with myeloma undergoing autologous stem cell transplantation: results from PERCEPT pilot randomised controlled trial. Acta Oncol 62(7):696\u2013705","journal-title":"Acta Oncol"},{"issue":"12","key":"10958_CR24","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1249\/MSS.0000000000003267","volume":"55","author":"JL Nicol","year":"2023","unstructured":"Nicol JL et al (2023) Safety, feasibility, and acceptability of a multisite individualized exercise intervention for people with multiple myeloma. Med Sci Sports Exerc 55(12):2214\u20132227","journal-title":"Med Sci Sports Exerc"},{"issue":"2","key":"10958_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.13793","volume":"16","author":"E Dreyling","year":"2025","unstructured":"Dreyling E et al (2025) A randomized controlled \u201cREAL-FITNESS\u201d trial to evaluate physical activity in patients with newly diagnosed multiple myeloma. J Cachexia Sarcopenia Muscle 16(2):e13793","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10958_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1471-2407-13-31","volume":"13","author":"L Groeneveldt","year":"2013","unstructured":"Groeneveldt L et al (2013) A mixed exercise training programme is feasible and safe and may improve quality of life and muscle strength in multiple myeloma survivors. BMC Cancer 13:31","journal-title":"BMC Cancer"},{"key":"10958_CR27","doi-asserted-by":"crossref","first-page":"205520762211290","DOI":"10.1177\/20552076221129066","volume":"8","author":"GM Purdy","year":"2022","unstructured":"Purdy GM et al (2022) Feasibility of a tailored and virtually supported home exercise program for people with multiple myeloma using a novel eHealth application. Digit Health 8:20552076221129064","journal-title":"Digit Health"},{"issue":"6","key":"10958_CR28","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1111\/ejh.14106","volume":"111","author":"U Dapunt","year":"2023","unstructured":"Dapunt U et al (2023) A precision-based exercise program for patients with multiple myeloma. Eur J Haematol 111(6):930\u2013937","journal-title":"Eur J Haematol"},{"issue":"10","key":"10958_CR29","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1007\/s00520-015-2680-2","volume":"23","author":"S Shallwani","year":"2015","unstructured":"Shallwani S et al (2015) Exercise compliance among patients with multiple myeloma undergoing chemotherapy: a retrospective study. Support Care Cancer 23(10):3081\u20133088","journal-title":"Support Care Cancer"},{"issue":"11","key":"10958_CR30","doi-asserted-by":"publisher","first-page":"9615","DOI":"10.1007\/s00520-022-07369-9","volume":"30","author":"MM Wefelnberg","year":"2022","unstructured":"Wefelnberg MM et al (2022) Clinical exercise therapy program with multiple myeloma patients: impacts on feasibility, adherence and efficacy. Support Care Cancer 30(11):9615\u20139623","journal-title":"Support Care Cancer"},{"key":"10958_CR31","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1186\/1471-2407-11-517","volume":"11","author":"DA Galvao","year":"2011","unstructured":"Galvao DA et al (2011) Efficacy and safety of a modular multi-modal exercise program in prostate cancer patients with bone metastases: a randomized controlled trial. BMC Cancer 11:517","journal-title":"BMC Cancer"},{"issue":"5","key":"10958_CR32","doi-asserted-by":"publisher","first-page":"e697","DOI":"10.1200\/OP.21.00454","volume":"18","author":"KL Campbell","year":"2022","unstructured":"Campbell KL et al (2022) Exercise recommendation for people with bone metastases: expert consensus for health care providers and exercise professionals. JCO Oncol Pract 18(5):e697\u2013e709","journal-title":"JCO Oncol Pract"},{"issue":"1","key":"10958_CR33","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.radonc.2014.06.008","volume":"112","author":"H Rief","year":"2014","unstructured":"Rief H et al (2014) The effect of resistance training during radiotherapy on spinal bone metastases in cancer patients - a randomized trial. Radiother Oncol 112(1):133\u2013139","journal-title":"Radiother Oncol"},{"issue":"1","key":"10958_CR34","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1186\/s13063-018-3091-8","volume":"19","author":"NH Hart","year":"2018","unstructured":"Hart NH et al (2018) Mechanical suppression of osteolytic bone metastases in advanced breast cancer patients: a randomised controlled study protocol evaluating safety, feasibility and preliminary efficacy of exercise as a targeted medicine. Trials 19(1):695","journal-title":"Trials"},{"key":"10958_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.841266","volume":"12","author":"H Luo","year":"2022","unstructured":"Luo H et al (2022) Adverse events reporting of clinical trials in exercise oncology research (ADVANCE): protocol for a scoping review. Front Oncol 12:841266","journal-title":"Front Oncol"},{"key":"10958_CR36","doi-asserted-by":"publisher","first-page":"4840531","DOI":"10.1155\/2018\/4840531","volume":"2018","author":"MG Benedetti","year":"2018","unstructured":"Benedetti MG et al (2018) The effectiveness of physical exercise on bone density in osteoporotic patients. Biomed Res Int 2018:4840531","journal-title":"Biomed Res Int"},{"issue":"10","key":"10958_CR37","doi-asserted-by":"publisher","first-page":"e419","DOI":"10.3324\/haematol.2016.144477","volume":"101","author":"M Hinge","year":"2016","unstructured":"Hinge M et al (2016) Bone healing in multiple myeloma: a prospective evaluation of the impact of first-line anti-myeloma treatment. Haematologica 101(10):e419\u2013e422","journal-title":"Haematologica"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10958-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-10958-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10958-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T14:55:53Z","timestamp":1786200953000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-026-10958-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10958"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-10958-7","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"assertion":[{"value":"23 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"759"}}